{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:49:08Z","timestamp":1777708148183,"version":"3.51.4"},"reference-count":39,"publisher":"Emerald","issue":"8","license":[{"start":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T00:00:00Z","timestamp":1348790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.emerald.com\/insight\/site-policies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,28]]},"abstract":"<jats:sec><jats:title content-type=\"abstract-heading\">Purpose<\/jats:title><jats:p>Obesity is a prevalent health problem among adult females in Egypt. The aim of this study is to investigate the use of drugs in managing of obesity among adult females.<\/jats:p><\/jats:sec><jats:sec><jats:title content-type=\"abstract-heading\">Design\/methodology\/approach<\/jats:title><jats:p>A random sample of 764 obese adult females with a BMI &gt;25 were included in the study. Data were collected using a pre\u2010coded questionnaire on personal characteristics, type of regimen followed, the use of anti\u2010obesity drugs, sources of information about medicine, compliance pattern and the outcome of using medicine.<\/jats:p><\/jats:sec><jats:sec><jats:title content-type=\"abstract-heading\">Findings<\/jats:title><jats:p>The results show that 19.9 per cent of the females took medicines while dieting and another 11.4 per cent while dieting and exercising. Physicians were the main source of advice about anti\u2010obesity medicine (33.1 per cent), followed by pharmacists (25.5 per cent), peers (24.2 per cent) and mass media (17.2 per cent). Medicines stimulating the metabolism were most commonly used (42.7 per cent), followed by drugs blocking fat absorption (24.3 per cent), appetite depressants (23.3 per cent) and herbs (18.4 per cent). The most common side effects were diarrhoea (30.1 per cent) followed by headache (20.1 per cent) and depression (17.2 per cent). The data show that 47.7 per cent of the females fully complied while 30.5 per cent did not comply. The intake of medicine while dieting induced weight loss among 48.9 per cent of the subjects, 18.0 per cent did not report weight loss and 33.1 per cent stopped medicine intake. Older females and those with a BMI &gt;35 were more keen to seek advice from a physician, were more likely to comply fully and reported the highest rate of weight loss. The use of anti\u2010obesity drugs was highest (44 per cent) among university graduates compared to 24.8 per cent among females with limited education.<\/jats:p><\/jats:sec><jats:sec><jats:title content-type=\"abstract-heading\">Originality\/value<\/jats:title><jats:p>This study presents the first report of the pattern of using anti\u2010obesity drugs in Egypt.<\/jats:p><\/jats:sec>","DOI":"10.1108\/09526861211270668","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T09:01:48Z","timestamp":1349341308000},"page":"730-741","source":"Crossref","is-referenced-by-count":3,"title":["A study of the use of drugs in the treatment of obesity among adult females"],"prefix":"10.1108","volume":"25","author":[{"given":"Sally","family":"Ezzat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"140","reference":[{"key":"key2022031120042970800_b1","doi-asserted-by":"crossref","unstructured":"Adan, R.H., Vanderschuren, J.M. and Lafleur, S.E. (2008), \u201cAnti\u2010obesity drugs and neural circuits of feeding\u201d, Trends in Pharmacological Sciences, Vol. 29 No. 4, pp. 208\u201017.","DOI":"10.1016\/j.tips.2008.01.008"},{"key":"key2022031120042970800_b2","doi-asserted-by":"crossref","unstructured":"Appolinarion, J.C. and McElrog, S.L. (2004), \u201cPharmacological approach in the treatment of binge eating disorder\u201d, Current Drug Targets, Vol. 5, pp. 301\u20107.","DOI":"10.2174\/1389450043490488"},{"key":"key2022031120042970800_b3","doi-asserted-by":"crossref","unstructured":"Arterburn, D. and Noel, P.H. (2001), \u201cExtracts from clinical evidence\u201d, British Medical Journal, Vol. 322, pp. 1406\u20109.","DOI":"10.1136\/bmj.322.7299.1406"},{"key":"key2022031120042970800_b4","doi-asserted-by":"crossref","unstructured":"Asfaw, A. (2007), \u201cMicronutrient deficiency and the prevalence of mothers' overweight\/obesity in Egypt\u201d, Economics and Human Biology, Vol. 5, pp. 471\u201083.","DOI":"10.1016\/j.ehb.2007.03.004"},{"key":"key2022031120042970800_b5","doi-asserted-by":"crossref","unstructured":"Astrup, A. (2001), \u201cHealthy life style in Europe: prevention of obesity and type II diabetes by diet and physical activity\u201d, Public Health Nutrition, Vol. 4 No. 2B, pp. 499\u2010515.","DOI":"10.1079\/PHN2001136"},{"key":"key2022031120042970800_b7","doi-asserted-by":"crossref","unstructured":"Bongain, A., Isnard, V. and Gillet, J.W. (1998), \u201cObesity in obstetrics and gynecology\u201d, European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 77, pp. 217\u20108.","DOI":"10.1016\/S0301-2115(97)00247-9"},{"key":"key2022031120042970800_b8","doi-asserted-by":"crossref","unstructured":"Cai\u2010Hong, H., Yu, K. and Mu\u2010ling, T. (2009), \u201cPatient needs and sources of drug information in Singapore. Is the internet replacing dormer sources?\u201d, Annals of Phamacology, Vol. 43 No. 44, pp. 732\u20109.","DOI":"10.1345\/aph.1L580"},{"key":"key2022031120042970800_b9","doi-asserted-by":"crossref","unstructured":"Chan, K. (2003), \u201cSome aspects of toxic contaminants in herbal medicines\u201d, Chemosphere, Vol. 52, pp. 1361\u201071.","DOI":"10.1016\/S0045-6535(03)00471-5"},{"key":"key2022031120042970800_b10","unstructured":"Danniel, W.W. (1995), Biostatistics. A Foundation for Analysis in the Health Sciences, 6th ed., Wiley, New York, NY."},{"key":"key2022031120042970800_b11","doi-asserted-by":"crossref","unstructured":"Diehl, A.K. (1991), \u201cEpidemiology and natural history of gallstone disease\u201d, Gastroenterology Clinics of North America, Vol. 20, pp. 1\u201019.","DOI":"10.1016\/S0889-8553(21)00531-8"},{"key":"key2022031120042970800_b12","unstructured":"Egypt Demographic and Health Survey (1996), National Population Council, Cairo."},{"key":"key2022031120042970800_b13","unstructured":"Egypt Demographic and Health Survey (2001), National Population Council, Cairo."},{"key":"key2022031120042970800_b14","doi-asserted-by":"crossref","unstructured":"Elfhang, K. and Rossner, S. (2005), \u201cWho succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain\u201d, Obesity Review, Vol. 6, pp. 67\u201085.","DOI":"10.1111\/j.1467-789X.2005.00170.x"},{"key":"key2022031120042970800_b15","doi-asserted-by":"crossref","unstructured":"Ernst, E. (2003), \u201cAdulteration of Chinese herbal medicines with synthetic drugs: a systematic review\u201d, Journal of Internal Medicine, Vol. 252, pp. 107\u201013.","DOI":"10.1046\/j.1365-2796.2002.00999.x"},{"key":"key2022031120042970800_b16","doi-asserted-by":"crossref","unstructured":"Fernandez\u2010Lopez, J.A., Remesar, X., Foz, M. and Alemany, M. (2002), \u201cPharmacological approaches for the treatment of obesity\u201d, Drugs, Vol. 62, pp. 915\u201044.","DOI":"10.2165\/00003495-200262060-00005"},{"key":"key2022031120042970800_b17","doi-asserted-by":"crossref","unstructured":"Finer, N. (2002), \u201cSibutramine: its mode of action and efficacy\u201d, International Journal of Obesity, Vol. 26, Supplement 4, pp. S29\u2010S33.","DOI":"10.1038\/sj.ijo.0802216"},{"key":"key2022031120042970800_b18","doi-asserted-by":"crossref","unstructured":"Finer, N., Ryan, D.H., Lenz, C.L. and Hewkin, A.C. (2006), \u201cPrediction of response to sibutramine therapy in obese non\u2010diabetic and diabetic patients\u201d, Diabetes, Obesity and Metabolism, Vol. 8, pp. 206\u201013.","DOI":"10.1111\/j.1463-1326.2005.00481.x"},{"key":"key2022031120042970800_b19","doi-asserted-by":"crossref","unstructured":"Fujoka, K. (2002), \u201cManagement of obesity as a chronic disease: nonrpharmacologic, pharmacologic and surgical options\u201d, Obesity Research, Vol. 10, Supplement 2, pp. 116S\u201023S.","DOI":"10.1038\/oby.2002.204"},{"key":"key2022031120042970800_b20","doi-asserted-by":"crossref","unstructured":"Gokcel, A., Gumurdulu, Y., Karakosa, H., Melek, E., Tanaci, N., Bascil, N. and Guvener, N. (2002), \u201cEvaluation of the safety and efficiency of sibutramine, orlistat and metaformin in the treatment of obesity\u201d, Diabetes, Obesity and Metabolism, Vol. 4, pp. 49\u201055.","DOI":"10.1046\/j.1463-1326.2002.00181.x"},{"key":"key2022031120042970800_b21","doi-asserted-by":"crossref","unstructured":"Golditz, G.A., Willett, W.C. and Rotnitzky Manson, J.E. (1995), \u201cWeight gain as a risk factor for clinical diabetes mellitus in women\u201d, Annals of Internal Medicine, Vol. 122, pp. 481\u20106.","DOI":"10.7326\/0003-4819-122-7-199504010-00001"},{"key":"key2022031120042970800_b22","unstructured":"Hassanyn, A.S. (2000), \u201cFood consumption pattern and nutrient intake among different population groups in Egypt\u201d, final report, Nutrition Institute, WHO\/EMRO, Cairo."},{"key":"key2022031120042970800_b23","doi-asserted-by":"crossref","unstructured":"Hendricks, E.J., Rothman, R.B. and Greenway, F.L. (2009), \u201cHow physician obesity specialists use drugs to treat obesity\u201d, Obesity, Vol. 179, pp. 1730\u20105.","DOI":"10.1038\/oby.2009.69"},{"key":"key2022031120042970800_b24","doi-asserted-by":"crossref","unstructured":"Horie, N.C., Cercato, C., Mancini, M.C. and Nalpern, A. (2010), \u201cLong\u2010term pharmacotherapy for obesity in elderly patients: a retrospective evaluation of medical records from a specialized obesity outpatient clinic\u201d, Drugs & Aging, Vol. 27, pp. 497\u2010502.","DOI":"10.2165\/11536660-000000000-00000"},{"key":"key2022031120042970800_b25","doi-asserted-by":"crossref","unstructured":"Inoue, S. (1995), \u201cClinical studies with mazindol\u201d, Obesity Research, Vol. 3, Supplement 4, pp. 549S\u201052S.","DOI":"10.1002\/j.1550-8528.1995.tb00226.x"},{"key":"key2022031120042970800_b26","doi-asserted-by":"crossref","unstructured":"Jung, J., Clausen, M.H. and Weinmann, W. (2006), \u201cAnorectic sibutramine detected in Chinese herbal drug for weight loss\u201d, Forensic Science International, Vol. 161, pp. 221\u20102.","DOI":"10.1016\/j.forsciint.2006.02.052"},{"key":"key2022031120042970800_b27","doi-asserted-by":"crossref","unstructured":"Kelley, D.E., Kuller, L.H., McKolanis, T., Harper, P., Mancino, J. and Kalhan, S. (2004), \u201cEffects of moderate weight loss and orlistat on insulin resistance, regional adiposity and fatty acids in type 2 diabetes\u201d, Diabetes Care, Vol. 27, pp. 33\u201040.","DOI":"10.2337\/diacare.27.1.33"},{"key":"key2022031120042970800_b28","doi-asserted-by":"crossref","unstructured":"Kuczmarski, R.J. (1992), \u201cPrevalence of overweight and weight gain in the United States\u201d, American Journal of Clinical Nutrition, Vol. 55, pp. 495S\u2010502S.","DOI":"10.1093\/ajcn\/55.2.495s"},{"key":"key2022031120042970800_b29","doi-asserted-by":"crossref","unstructured":"Leung, W.Y., Thomas, G.N., Chan, J.C. and Tomlinson, B. (2003), \u201cWeight management and current options in pharmacology: orlistat and sibutramine\u201d, Clinical Therapeutics, Vol. 25 No. 1, pp. 58\u201080.","DOI":"10.1016\/S0149-2918(03)90009-9"},{"key":"key2022031120042970800_b30","doi-asserted-by":"crossref","unstructured":"McDuffee, J.R., Calis, K.A., Booth, S.L., Uwaifo, G.I. and Yanovski, J.A. (2002), \u201cEffects of orlistat on fat soluble vitamins in obese adolescents\u201d, Pharmacotherapy, Vol. 22, pp. 814\u201022.","DOI":"10.1592\/phco.22.11.814.33627"},{"key":"key2022031120042970800_b31","doi-asserted-by":"crossref","unstructured":"Manson, J.E., Willet, W.C. and Stampfer, M.J. (1995), \u201cBody weight and mortality among women\u201d, New England Journal of Medicine, Vol. 333, pp. 677\u201084.","DOI":"10.1056\/NEJM199509143331101"},{"key":"key2022031120042970800_b32","doi-asserted-by":"crossref","unstructured":"Moran, L.J. and Norman, R.J. (2002), \u201cThe obese patient with infertility: a practical approach to diagnosis and treatment\u201d, Nutrition in Clinical Care, Vol. 5, pp. 290\u20107.","DOI":"10.1046\/j.1523-5408.2002.05604.x"},{"key":"key2022031120042970800_b33","doi-asserted-by":"crossref","unstructured":"Narhi, U. and Helakorpi, S. (2007), \u201cSources of medicine information in Finland\u201d, Health Policy, Vol. 84 No. 1, pp. 51\u20107.","DOI":"10.1016\/j.healthpol.2007.05.005"},{"key":"key2022031120042970800_b34","unstructured":"Ozcelik, O., Dogan, H. and Kelestimur, H. (2004), \u201cEffects of weight loss induced by eight week orlistat therapy on maximal work production capacity in obese females\u201d, Turkish Journal of Medical Science, Vol. 34, pp. 49\u201054."},{"key":"key2022031120042970800_b35","doi-asserted-by":"crossref","unstructured":"Popkin, B.M. (2001), \u201cThe nutrition transition and obesity in the developing world\u201d, Journal of Nutrition, Vol. 131, pp. 8715\u2010835.","DOI":"10.1093\/jn\/131.3.871S"},{"key":"key2022031120042970800_b36","doi-asserted-by":"crossref","unstructured":"Rexrode, K.M., Manson, J.E. and Hennekens, G.H. (1996), \u201cObesity and cardiovascular disease\u201d, Current Opinion in Cardiology, Vol. 11, pp. 490\u20105.","DOI":"10.1097\/00001573-199609000-00007"},{"key":"key2022031120042970800_b37","doi-asserted-by":"crossref","unstructured":"Scheen, A. (2003), \u201cCurrent management strategies for coexisting diabetes mellitus and obesity\u201d, Drugs, Vol. 63, pp. 1165\u201084.","DOI":"10.2165\/00003495-200363120-00001"},{"key":"key2022031120042970800_b38","doi-asserted-by":"crossref","unstructured":"Tawfik, A.A., Hathout, M.H. and Shaheen, M.F. (2003), \u201cPrevalence of obesity in Egypt\u201d, Bulletin of the High Institute of Public Health, Vol. 33, pp. 895\u2010926.","DOI":"10.21608\/jhiph.2003.193526"},{"key":"key2022031120042970800_b39","unstructured":"WHO (2000), \u201cObesity: preventing and managing the global epidemic\u201d, WHO Technical Report Series No. 894, World Health Organization, Geneva, pp. 39\u201048."},{"key":"key2022031120042970800_frg1","doi-asserted-by":"crossref","unstructured":"Astrup, A. and Rossner, S. (2000), \u201cLessons from obesity management programmes: greater initial weight loss improves long term maintenance\u201d, Obesity Reviews, Vol. 1, pp. 17\u201019.","DOI":"10.1046\/j.1467-789x.2000.00004.x"}],"container-title":["International Journal of Health Care Quality Assurance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.emeraldinsight.com\/doi\/full-xml\/10.1108\/09526861211270668","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/09526861211270668\/full\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/09526861211270668\/full\/html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:29:55Z","timestamp":1753403395000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.emerald.com\/ijhcqa\/article\/25\/8\/730-741\/121923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,28]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,9,28]]}},"alternative-id":["10.1108\/09526861211270668"],"URL":"https:\/\/doi.org\/10.1108\/09526861211270668","relation":{},"ISSN":["0952-6862"],"issn-type":[{"value":"0952-6862","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,28]]}}}